Fusion Antibodies is delighted to be attending the 19th Annual Anglonordic Life Science Conference taking place on 20th April 2023 in the County Hall, London. The conference brings together key decision makers at leading and upcoming drug discovery and technology companies from across the UK and Nordic regions, and investment firms throughout Europe.

Our Alliance Director Brett Whitecross will be attending this event. If you would like to set up a meeting to discuss our capabilities or to find out more about how we can advance your project to the next stage, please contact us here.

About Fusion Antibodies

Fusion Antibodies is an end-to-end antibody discovery partner offering a range of services in antibody generation, development, production, characterisation, and optimisation.

We have guided hundreds of projects through critical pre-clinical stages, repeatedly proving our expertise as we strive to bring about a positive change in the healthcare industry.